A Cannabis Breath-and-Blood Test’s 100% Result Was Not a Driving Validation
A reported 100% positive result after cannabis smoking does not establish 100% accuracy for driving impairment. A combined breath-and-blood study developed a recent-use classification using a selected smoking cohort and an impairment framework based largely on self-report.
The full test required more than one breath sample
The study recruited 74 cannabis users. Forty-four supplied breath as well as blood; baseline breath assessments were available for 34. Participants smoked cannabis cigarettes of varying THC content, and researchers examined cannabinoid signals over time.
The proposed approach combined changes between breath samples, additional cannabinoids and a breath-to-blood THC signal ratio. The blood was capillary whole blood. The ratio used analyte-to-internal-standard peak-area ratios, not a generally transferable breath concentration divided by a venous blood concentration.
Recent smoking was the demonstrated exposure
The authors reported positive combined classifications for all 44 participants after smoking within their designated window and none of the 34 tested at baseline. Those counts are development-study findings. They do not demonstrate performance in a separate, prospectively tested population with independently defined driving impairment.
Participants rated impairment on a ten-point scale, and horizontal gaze nystagmus was assessed in a subset. No standardized on-road or simulator performance endpoint served as the reference for the headline classification. Six of the 74 participants still reported some impairment outside the approximately three-hour window described by the authors.
What an independent validation would need
A driving-impairment claim needs a specified functional reference, a prespecified decision rule and testing in people beyond those used to develop that rule. It should report false classifications and uncertainty across timing, use histories and products. The authors’ disclosed testing patents and commercial affiliations further underscore the value of independent evaluation.
The method was developed for inhaled cannabis, and the paper acknowledged that oral products require further study. Its recent-use findings should not become an individual three-hour driving clearance or proof that every chemically classified person was functionally impaired.
Related: the separate analysis of baseline and post-smoking breath THC.
Primary research
A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window. DOI: 10.1038/s41598-021-02137-x.
